Paper41810102
Tumor Vaccines in Hepatocellular Carcinoma: Advances, Challenges, and the Path Toward Precision Immunotherapy.
Niu B and 2 others. J Clin Transl Hepatol, 2026. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Tumor Vaccines in Hepatocellular Carcinoma: Advances, Challenges, and the Path Toward Precision Immunotherapy. Papers, record 41810102. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41810102
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Tumor Vaccines in Hepatocellular Carcinoma: Advances, Challenges, and the Path Toward Precision Immunotherapy.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References100
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39073133 | Adeno-associated viral vector gene therapy: Challenges for the paediatric hepatologist. | J Pediatr Gastroenterol Nutr | 2024 | https://conductscience.org/library/papers/39073133 | PubMed |
| 2 | 36339710 | Identifying tumor immunity-associated molecular features in liver hepatocellular carcinoma by multi-omics analysis. | Front Mol Biosci | 2022 | https://conductscience.org/library/papers/36339710 | PubMed |
| 3 | 41042291 | Clinical performance of GAAD score, alpha-fetoprotein, and PIVKA-II in diagnosing hepatocellular carcinoma in the Vietnamese cohort. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41042291 | PubMed |
| 4 | 35488312 | Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses. | J Hematol Oncol | 2022 | https://conductscience.org/library/papers/35488312 | PubMed |
| 5 | 37552209 | Spleen-targeted neoantigen DNA vaccine for personalized immunotherapy of hepatocellular carcinoma. | EMBO Mol Med | 2023 | https://conductscience.org/library/papers/37552209 | PubMed |
| 6 | 32774053 | Intratumoral heterogeneity of hepatocellular carcinoma: From single-cell to population-based studies. | World J Gastroenterol | 2020 | https://conductscience.org/library/papers/32774053 | PubMed |
| 7 | 36313716 | An OX40L mRNA vaccine inhibits the growth of hepatocellular carcinoma. | Front Oncol | 2022 | https://conductscience.org/library/papers/36313716 | PubMed |
| 8 | 38086815 | Therapeutic cancer vaccines: advancements, challenges, and prospects. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/38086815 | PubMed |
| 9 | 29567706 | Personalized vaccines for cancer immunotherapy. | Science | 2018 | https://conductscience.org/library/papers/29567706 | PubMed |
| 10 | 29344179 | In vivo antitumor activity evaluation of cancer vaccines prepared by various antigen forms in a murine hepatocellular carcinoma model. | Oncol Lett | 2017 | https://conductscience.org/library/papers/29344179 | PubMed |
| 11 | 36901717 | Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36901717 | PubMed |
| 12 | 32565925 | Combination therapy with dendritic cell vaccine and programmed death ligand 1 immune checkpoint inhibitor for hepatocellular carcinoma in an orthotopic mouse model. | Ther Adv Med Oncol | 2020 | https://conductscience.org/library/papers/32565925 | PubMed |
| 13 | 36968540 | Discovery of New States of Immunomodulation for Vaccine Adjuvants via High Throughput Screening: Expanding Innate Responses to PRRs. | ACS Cent Sci | 2023 | https://conductscience.org/library/papers/36968540 | PubMed |
| 14 | 36071839 | Link of sorafenib resistance with the tumor microenvironment in hepatocellular carcinoma: Mechanistic insights. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36071839 | PubMed |
| 15 | 33540942 | Lipid Nanoparticles as Delivery Systems for RNA-Based Vaccines. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/33540942 | PubMed |
| 16 | 28233802 | Targeting neoantigens to augment antitumour immunity. | Nat Rev Cancer | 2017 | https://conductscience.org/library/papers/28233802 | PubMed |
| 17 | 40125432 | Enhanced Antitumor Immunity Through T Cell Activation with Optimized Tandem Double-OX40L mRNAs. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/40125432 | PubMed |
| 18 | 39731178 | Cancer Organoids as reliable disease models to drive clinical development of novel therapies. | J Exp Clin Cancer Res | 2024 | https://conductscience.org/library/papers/39731178 | PubMed |
| 19 | 16675576 | A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides. | Clin Cancer Res | 2006 | https://conductscience.org/library/papers/16675576 | PubMed |
| 20 | 36260016 | Advances in nanoparticle-based mRNA delivery for liver cancer and liver-associated infectious diseases. | Nanoscale Horiz | 2022 | https://conductscience.org/library/papers/36260016 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42646710 | The State-of-the Art of Personalized Vaccines for Non-Communicable Diseases: A Narrative Review. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42646710 | PubMed |
| 42646677 | Bidirectional Interplay Between Tumor Vaccines and the Tumor Microenvironment: Mechanisms, Cold-to-Hot Conversion, and Combination Strategies. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42646677 | PubMed |
Genes29
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41810102
GET https://conductscience.org/api/papers/v1/41810102/references?page=2